- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- Egalet, Shionogi to develop abuse-deterrent opioids
- Study: OTC ibuprofen as effective as Rx in treating post-operative pain after having tonsils removed
- FDA issues sweeping new requirements for long-acting opioids
- Teva, Mylan launch Viagra generics in Europe
PITTSBURGH — Mylan has launched a generic version of an opioid painkiller, the company said Wednesday.
Mylan announced the launch of oxycodone hydrochloride tablets in the 5-mg, 15-mg and 30-mg strengths. Mylan is launching the drug under a development and supply agreement with Coastal Pharmaceuticals.
The drug is a generic version of Xanodyne’s Roxicodone, a treatment for moderate to severe pain. Oxycodone hydrochloride tablets had sales of about $325 million during the 12-month period ended in March, according to IMS Health.